Next Generation: Gregg Gellman, COO of StimMed and innovator
Sunday, January 27, 2019
Source: The Buffalo News
Gregg Gellman is one of the most active innovators in local health-care startups.
The 49-year-old Amherst native got into the field after taking business and English classes at SUNY Buffalo State. At what is now Zimmer Biomet, his clinical observations on follow-up patient visits convinced him of the need for better post-surgery wound care for high-risk patients.
At Greatbatch, he gained experience in bringing advanced tech products to market. He then took positions with 22nd Century Group, where he led some regulatory approval efforts, and Garwood Medical Devices, where he remains a major shareholder.
Now StimMed's chief operating officer, he leads commercialization efforts for a device using electrical stimulation to increase blood flow in the lower extremities to prevent deep vein thrombosis.
Gellman also has helped raise nearly $18 million for 22nd Century, Garwood and StimMed. He said the key is discovering disruptive technologies and applying them effectively and inexpensively to a current medical procedure.